Peter George
Chairman
Chemistry
Ergomed plc
United Arab Emirates
Biography
Peter George joined Ergomed as a non-executive director in May 2014 and has over 20 years’ experience in the pharmaceutical services industry. Peter stepped down as Chief Executive Officer of Clinigen Group plc (AIM: CLIN) at the end of 2016. He started Clinigen in 2010 as a global specialty pharmaceuticals and pharmaceutical services business and by 2016 it had a c.£1bn market cap, being one of the most successful recent floats on AIM. Prior to Clinigen, he was CEO at Penn Pharma, having led a £67m management buy-out in 2007. Before this, Peter was executive Vice President for Wolters Kluwer Health with responsibility for Europe and Asia Pacific regions. Peter has also held roles as the Chief Operating Officer of Unilabs Clinical Trials International Limited, and Head of Clinical Pathology NHS. Peter is also Chairman of Wichtig International, Mitre Group Limited, XPG Ltd and Marco Polo Events Limited, companies he owns or has significant holdings in.
Research Interest
Chemistry
